125 related articles for article (PubMed ID: 2411575)
1. Progabide reverses the nigral substance P reduction induced by chronic impairment of dopaminergic transmission.
Zivkovic B; Oblin A; Bartholini G
Eur J Pharmacol; 1985 Jun; 112(2):253-5. PubMed ID: 2411575
[TBL] [Abstract][Full Text] [Related]
2. Selective antagonists of dopamine receptor subtypes differentially affect substance P levels in the striatum and substantia nigra.
Oblin A; Zivkovic B; Bartholini G
Brain Res; 1987 Sep; 421(1-2):387-90. PubMed ID: 2446703
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the D-2 dopamine receptor in the neuroleptic-induced decrease in nigral substance P.
Oblin A; Zivkovic B; Bartholini G
Eur J Pharmacol; 1984 Oct; 105(1-2):175-7. PubMed ID: 6208042
[TBL] [Abstract][Full Text] [Related]
4. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat striatal neurons.
Kerkerian L; Salin P; Nieoullon A
Neuroscience; 1988 Sep; 26(3):809-17. PubMed ID: 3143926
[TBL] [Abstract][Full Text] [Related]
6. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.
Lindefors N; Brodin E; Tossman U; Segovia J; Ungerstedt U
Exp Brain Res; 1989; 74(3):527-34. PubMed ID: 2468514
[TBL] [Abstract][Full Text] [Related]
7. A physiological role for dopamine as modulator of GABA effects in substantia nigra: supersensitivity in 6-hydroxydopamine-lesioned rats.
Waszczak BL; Walters JR
Eur J Pharmacol; 1984 Oct; 105(3-4):369-73. PubMed ID: 6439567
[TBL] [Abstract][Full Text] [Related]
8. The effects of dopamine and dopamine agonists on the release of 3H-GABA and 3H-5HT from rat nigral slices.
Kelly E; Jenner P; Marsden CD
Biochem Pharmacol; 1985 Aug; 34(15):2655-62. PubMed ID: 3925957
[TBL] [Abstract][Full Text] [Related]
9. Haloperidol-induced reduction of nigral substance P-like immunoreactivity: a probe for the interactions between dopamine and substance P neuronal systems.
Hanson GR; Alphs L; Wolf W; Levine R; Lovenberg W
J Pharmacol Exp Ther; 1981 Aug; 218(2):568-74. PubMed ID: 6166743
[TBL] [Abstract][Full Text] [Related]
10. Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system.
Humpel C; Knaus GA; Auer B; Knaus HG; Haring C; Theodorsson E; Saria A
Synapse; 1990; 6(1):1-9. PubMed ID: 1697986
[TBL] [Abstract][Full Text] [Related]
11. Nigrostriatal dopamine neurons are required to maintain basal levels of substance P in the rat substantia nigra.
Cruz CJ; Beckstead RM
Neuroscience; 1989; 30(2):331-8. PubMed ID: 2473415
[TBL] [Abstract][Full Text] [Related]
12. The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat.
Bolam JP; Smith Y
Brain Res; 1990 Oct; 529(1-2):57-78. PubMed ID: 1704287
[TBL] [Abstract][Full Text] [Related]
13. [3H] Quinuclidinyl benzylate and [3H] GABA receptor binding in rat substantia nigra after 6-hydroxy-dopamine lesions.
Cross AJ; Waddington JL
Neurosci Lett; 1980 May; 17(3):271-5. PubMed ID: 6302586
[TBL] [Abstract][Full Text] [Related]
14. D1 dopamine receptor-mediated substance P depletion in the striatonigral neurons of rats subjected to neonatal dopaminergic denervation: implications for self-injurious behavior.
Sivam SP
Brain Res; 1989 Oct; 500(1-2):119-30. PubMed ID: 2481560
[TBL] [Abstract][Full Text] [Related]
15. Acute changes in nigral substance P content induced by drugs acting on dopamine, muscarine and GABA receptors.
Koshiya K; Kato T
Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):223-7. PubMed ID: 6197660
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of gamma-aminobutyric acid (GABA)-elevating agents on the neuroleptic-induced activation of striatal tyrosine-hydroxylase: evidence that di-n-propylacetate augments GABAergic neurotransmission.
Casu M; Gale K
J Pharmacol Exp Ther; 1981 Apr; 217(1):177-80. PubMed ID: 6110774
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the presence of dopaminergic neurons and GABA receptors in substantia nigra: effects of lesions.
Gale K
Brain Res; 1981 Apr; 210(1-2):401-6. PubMed ID: 6112044
[TBL] [Abstract][Full Text] [Related]
18. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
19. Intranigral application of substance P antagonists prevents the haloperidol-induced activation of striatal tyrosine hydroxylase.
Melis MR; Gale K
Naunyn Schmiedebergs Arch Pharmacol; 1984 May; 326(1):83-6. PubMed ID: 6206401
[TBL] [Abstract][Full Text] [Related]
20. Quantitative radioimmunocytochemical evidence that haloperidol and SCH 23390 induce opposite changes in substance P levels of rat substantia nigra.
Cruz CJ; Beckstead RM
Brain Res; 1988 Aug; 457(1):29-43. PubMed ID: 2458801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
